
SAKK 08/07: Docetaxel and cetuximab in patients with docetaxel-resistant hormone-refractory prostate cancer. A multicenter phase II trial. Immunohistochemical analysis of biomarkers
Research Project | 01.01.2011 - 30.06.2011
|
01.01.2011
- 30.06.2011